Global Anti-Viral Drugs Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI46491
  • March 20, 2019
  • Global
  • 96 pages
  • QY Market Research
                                              "The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Anti-Viral Drugs market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Anti-Viral Drugs market."
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones

The global Anti-Viral Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Viral Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Viral Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    F. Hoffmann-La Roche
    GlaxoSmithKline
    Bristol-Myers-Squibb
    AbbVie
    Johnson & Johnson
    Merck & Co
    Aurobindo Pharma
    Cipla
    Dr Reddys

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Nucleotide Polymerase Inhibitor
    Reverse Transcriptase Inhibitor
    Protease Inhibitor

Segment by Application
    HIV
    Hepatitis
    HSV
    Influenza
 

Table of Contents

Executive Summary
1 Anti-Viral Drugs Market Overview
    1.1 Product Overview and Scope of Anti-Viral Drugs
    1.2 Anti-Viral Drugs Segment by Type
        1.2.1 Global Anti-Viral Drugs Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Nucleotide Polymerase Inhibitor
        1.2.3 Reverse Transcriptase Inhibitor
        1.2.4 Protease Inhibitor
    1.3 Anti-Viral Drugs Segment by Application
        1.3.1 Anti-Viral Drugs Consumption Comparison by Application (2014-2025)
        1.3.2 HIV
        1.3.3 Hepatitis
        1.3.4 HSV
        1.3.5 Influenza
    1.4 Global Anti-Viral Drugs Market by Region
        1.4.1 Global Anti-Viral Drugs Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Anti-Viral Drugs Market Size
        1.5.1 Global Anti-Viral Drugs Revenue (2014-2025)
        1.5.2 Global Anti-Viral Drugs Production (2014-2025)

2 Global Anti-Viral Drugs Market Competition by Manufacturers
    2.1 Global Anti-Viral Drugs Production Market Share by Manufacturers (2014-2019)
    2.2 Global Anti-Viral Drugs Revenue Share by Manufacturers (2014-2019)
    2.3 Global Anti-Viral Drugs Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Anti-Viral Drugs Production Sites, Area Served, Product Types
    2.5 Anti-Viral Drugs Market Competitive Situation and Trends
        2.5.1 Anti-Viral Drugs Market Concentration Rate
        2.5.2 Anti-Viral Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Viral Drugs Production Market Share by Regions
    3.1 Global Anti-Viral Drugs Production Market Share by Regions
    3.2 Global Anti-Viral Drugs Revenue Market Share by Regions (2014-2019)
    3.3 Global Anti-Viral Drugs Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Anti-Viral Drugs Production
        3.4.1 North America Anti-Viral Drugs Production Growth Rate (2014-2019)
        3.4.2 North America Anti-Viral Drugs Production, Revenue, Price and ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form